ch.oddb.org  
   
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Drugs alphabetical "v", total number of products: 434
Reg.‑No.  ProductComposition 
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9
1 - 100101 - 200201 - 300301 - 400401 - 434
60326IPCIVotrient 200 mgCoated tablets: Pazopanibum 200 mg
60326IPCIVotrient 400 mgCoated tablets: Pazopanibum 400 mg
62812IPCIVotubia 2 mgDispersible Tablets: Everolimusum 2 mg
62061IPCIVotubia 2.5 mgTablets: Everolimusum 2.5 mg
62812IPCIVotubia 3 mgDispersible Tablets: Everolimusum 3 mg
62061IPCIVotubia 5 mgTablets: Everolimusum 5 mg
57142IPCIVotum 10 mgCoated tablets: Olmesartanum Medoxomilum 10 mg
57142IPCIVotum 20 mgCoated tablets: Olmesartanum Medoxomilum 20 mg
57142IPCIVotum 40 mgCoated tablets: Olmesartanum Medoxomilum 40 mg
57554IPCIVotum plus 20/12.5Coated tablets: 2 Active Agents
57554IPCIVotum plus 20/25Coated tablets: 2 Active Agents
57554IPCIVotum plus 40/12.5Coated tablets: 2 Active Agents
57554IPCIVotum plus 40/25Coated tablets: 2 Active Agents
69569IPCIVoxzogo 0.4 mgLyophilisate and solvent: Vosoritidum
69569IPCIVoxzogo 0.56 mgLyophilisate and solvent: Vosoritidum
69569IPCIVoxzogo 1.2 mgLyophilisate and solvent: Vosoritidum 1.2 mg
69301IPCIVoydeya 100 mgCoated tablets: Danicopanum 100 mg
69301IPCIVoydeya 50 mg / 100 mgCoated tablets: Danicopanum 50 mg
Coated tablets: Danicopanum 100 mg
61297IPCIVPRIV 400 ULyophilisate: Velaglucerasum Alfa 400 U
66314IPCIVroni Gynialüberzogene Tablette: 2 Active Agents
69761IP Vueway
69760IP Vueway
68066IPCIVumerity 231 mgGastric-juice-resistant Capsules: Diroximeli Fumaras 231 mg
69035IPCIVydura 75 mgSoluble Powder: Rimegepantum 75 mg
67995IP Vyepti 100 mg/1 mlConcentrate for infusion: Eptinezumabum 100 mg/ml
67995IP Vyepti 300 mg/3 mlConcentrate for infusion: Eptinezumabum 300mg / 3ml
69501IP Vyloy 100 mgPulver für ein Konzentrat zur Herstellung einer Infusionslösung: Zolbetuximabum 100 mg
69501IP Vyloy 300 mgPulver für ein Konzentrat zur Herstellung einer Infusionslösung: Zolbetuximabum 300 mg
67083IPCIVyndaqel 20 mgSoft capsules: Tafamidisum Megluminum 20 mg
67518IPCIVyndaqel 61 mgSoft capsules: Tafamidisum 61 mg
70518IP Vyvgart 1000 mg/ 5 mlsolution injectable en seringue préremplie: Efgartigimodum Alfa 1000mg / 5ml
69725IP Vyvgart 1000 mg/ 5.6 mlInjection solution: Efgartigimodum Alfa 1000mg / 5.6ml
69286IP Vyvgart 400 mg/20mlConcentrate for infusion: Efgartigimodum Alfa 400mg / 20ml
68014IP Vyxeos liposomal 44 mg/100 mgPulver für ein Konzentrat zur Herstellung einer Infusionsdispersion: 2 Active Agents
 show caption
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home